Type 1 Diabetes Trial, Recruiting NCT06050642 Sponsor: timkl Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT06050642
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who have Type 1 diabetes
  • People who have been using a closed-loop system or insulin pump for at least 6 months
  • People who are experiencing moderate or high levels of diabetes-related emotional distress, based on a specific questionnaire score (a DDS2 score of 6 or higher)
  • People who are able to understand and fill in questionnaires written in French
  • People who are registered under the standard French Social Security system
  • People who have an email address
  • People who have a mobile phone number

Who may not be able to join:

  • People who are currently in prison, or who are under legal guardianship or curatorship
  • People who do not have internet access or do not own a mobile phone
  • People who have already taken part in, or are currently taking part in, a specific enhanced care support programme connected to this trial
  • People who are currently taking part in another research study involving a diabetes medical device (such as an insulin pump or glucose sensor)
  • People who are not regularly seen at the clinic proposing to enrol them, or who are likely to move to a different area or change their pharmacy within one year of joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bruno GUERCI, MD PhD, Central Hospital, Nancy, France

Phone: +33 4 76 52 67 49

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
timkl
Registry
ClinicalTrials.gov
Start date
4 September 2023
Est. completion
1 October 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in the 7-question Type-1 Diabetes Distress Score (T1-DDS-7) [Comparison: Enhanced Care vs Standard Care]

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov